Technology vs Healthcare

The technology-to-healthcare ratio divides the total return of the technology sector by the total return of the healthcare sector, rebased to 100 at the start of their common history in 1998. It is not a price — it is a measure of relative performance. When the line rises, the technology sector is outperforming the healthcare sector; when it falls, the reverse is true. A reading of 100 means the two have delivered identical cumulative returns since 1998.

Because the comparison uses total return, any income each asset pays — dividends, coupons — is reinvested, so the line reflects the full wealth journey of holding one versus the other rather than price alone. That is the fair way to compare assets with very different payout profiles, and it is why the rebased line can diverge sharply from a simple price chart over long horizons.

Over the full 28-year history shown above, the ratio has moved +94.9% on a rebased basis (100 → 194.9), which works out to roughly +2.4% per year of relative performance. On balance, the technology sector has been the stronger performer of the two over this window; the current reading sits above the starting line of 100, meaning the healthcare sector would have needed to close that gap to catch up.

The ratio has ranged from a low near 36.6 to a high near 194.9 over the period, so the relative-performance story has not been one-directional — there have been multi-year stretches in which the laggard pulled ahead. The wider that range, the more the lead has changed hands, and the more this pairing has behaved like two genuinely different exposures rather than two versions of the same bet.

Zooming in on the recent record, the ratio is +42.9% over the past 12 months, +121.9% over five years, +322.0% over ten years. Reading these windows together shows whether the longer-run trend is still intact or whether leadership has rotated: a long-run direction that disagrees with the one-year move is often the signature of a regime change in progress.

Short windows are noisier than long ones, and a single strong or weak year can dominate the 12-month figure. The value of the rebased line is that it puts those recent moves in the context of decades, so a sharp recent swing can be judged against how far the two assets have diverged and converged before.

Relative performance between the technology sector and the healthcare sector is driven mainly by the macro regime: the balance of economic growth, the direction of inflation, the level of real interest rates, and the appetite for risk. Each asset responds differently to those forces, so the ratio is really a running tally of which environment has prevailed. The macro-regime panel above places the latest reading against that backdrop.

No single factor explains every move, and the relationship is not mechanical. The ratio compounds many overlapping cycles — monetary policy, the business cycle, shifts in sentiment — which is why it is most informative over multi-year windows rather than month to month.

Each month the chart takes the total-return index of the technology sector, divides it by the total-return index of the healthcare sector, and rebases the result to 100 at the first month both have data. Both legs are resampled to month-end and inner-joined on the calendar month, so the line reflects a like-for-like comparison through time. Total-return indices reinvest dividends and coupons, so the comparison captures income as well as price.

Two caveats apply. The line is a ratio of two indices, not a tradable spread, and it excludes real-world frictions such as fees, taxes, and bid-ask spreads. And because it is rebased to 100 at the start, the level is meaningful only relative to its own history — what matters is the direction and the distance travelled, not the absolute number.

The regime context above frames whether the current environment has historically favored the technology sector or the healthcare sector. The most useful way to read the ratio is alongside that backdrop: is the recent direction of the line consistent with the prevailing growth, inflation, and risk conditions, or is it diverging from them? Divergences are often where the most information sits.

This is a historical indicator, not a forecast or investment advice. The aim is to show how two exposures have actually behaved relative to each other through real macro cycles, and to put today's reading in that long-run context — not to suggest what either will do next.